Search results

  1. CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.

    CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone …

  2. Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.

    … of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies. Journal …

  3. Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada.

    … Antibodies for the Treatment of Diffuse Large B-Cell Lymphoma in Canada. Journal …

  4. Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma.

    … Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma. Journal J Clin …

  5. Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.

    … parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab. …

  6. Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study.

    … rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study. Journal …

  7. Diffuse large B-cell lymphoma.

    Diffuse large B-cell lymphoma. Journal Hematol …

  8. The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.

    … and patient characteristics on survival in plasmablastic lymphoma. Journal Blood, …

  9. Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

    … as Frontline Therapy in Older Adults With Hodgkin Lymphoma. Journal J Clin …

  10. Axicabtagene ciloleucel compared to standard of care in Canadian patients with relapsed or refractory large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial.

    … Canadian patients with relapsed or refractory large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial. …

Back to top